XBI icon

SPDR S&P Biotech ETF

738 hedge funds and large institutions have $8.01B invested in SPDR S&P Biotech ETF in 2023 Q4 according to their latest regulatory filings, with 142 funds opening new positions, 170 increasing their positions, 268 reducing their positions, and 67 closing their positions.

Holders
738
Holders Change
+65
Holders Change %
+9.66%
% of All Funds
10.82%
Holding in Top 10
23
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+35.29%
% of All Funds
0.34%
New
142
Increased
170
Reduced
268
Closed
67
Calls
$2.01B
Puts
$3.26B
Net Calls
-$1.25B
Net Calls Change
-$765M
Name Market Value Shares Shares
Change
Shares
Change %
EW
801
Element Wealth
Mississippi
-104 Closed
C
802
Covestor
United Kingdom
-72 Closed
HI
803
Hoey Investments
Pennsylvania
-70 Closed
WT
804
Washington Trust
Rhode Island
-50 Closed
Legacy Financial Group (Iowa)
805
Legacy Financial Group (Iowa)
Iowa
-45 Closed
TFA
806
Toth Financial Advisory
Virginia
-20 Closed
ANBT
807
American National Bank & Trust
Texas
-6 Closed
RA
808
Rosalind Advisors
Ontario, Canada
TM
809
Triatomic Management
California
KCM
810
Kingdon Capital Management
New York
GL
811
Governors Lane
New York
Nomura Holdings
812
Nomura Holdings
Japan
CC
813
Checkpoint Capital
California
HT
814
HAP Trading
New York
IC
815
Ikarian Capital
Texas
PCM
816
Pentwater Capital Management
Florida
EIM
817
Elliott Investment Management
Florida
NCM
818
Nantahala Capital Management
Connecticut
BHCM
819
Brevan Howard Capital Management
Jersey
WAM
820
Weiss Asset Management
Massachusetts
JGC
821
J. Goldman & Co
New York
Walleye Capital
822
Walleye Capital
New York
Point72 Asset Management
823
Point72 Asset Management
Connecticut
UOC
824
UBS O'Connor
Illinois
AWM
825
Activest Wealth Management
Florida